EN
With EPS Growth And More, Amanta Healthcare (NSE:AMANTA) Makes An Interesting Case
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage to find investors. But the reality is that when a company loses money each year, for long enough, its investors will usually take their share of those losses. Loss-making companies are always racing against time to reach financial sustainability, so investors in these companies may be taking on more risk than they should.
In contrast to all that, many investors prefer to focus on companies like Amanta Healthcare (NSE:AMANTA), which has not only revenues, but also profits. Even if this company is fairly valued by the market, investors would agree that generating consistent profits will continue to provide Amanta Healthcare with the means to add long-term value to shareholders.
How Fast Is Amanta Healthcare Growing Its Earnings Per Share?
In the last three years Amanta Healthcare's earnings per share took off; so much so that it's a bit disingenuous to use these figures to try and deduce long term estimates. Thus, it makes sense to focus on more recent growth rates, instead. Amanta Healthcare boosted its trailing twelve month EPS from ₹4.25 to ₹4.72, in the last year. This amounts to a 11% gain; a figure that shareholders will be pleased to see.
Careful consideration of revenue growth and earnings before interest and taxation (EBIT) margins can help inform a view on the sustainability of the recent profit growth. While we note Amanta Healthcare achieved similar EBIT margins to last year, revenue grew by a solid 10% to ₹3.0b. That's encouraging news for the company!
In the chart below, you can see how the company has grown earnings and revenue, over time. Click on the chart to see the exact numbers.
See our latest analysis for Amanta Healthcare
Since Amanta Healthcare is no giant, with a market capitalisation of ₹7.6b, you should definitely check its cash and debt before getting too excited about its prospects.
Are Amanta Healthcare Insiders Aligned With All Shareholders?
Insider interest in a company always sparks a bit of intrigue and many investors are on the lookout for companies where insiders are putting their money where their mouth is. Because often, the purchase of stock is a sign that the buyer views it as undervalued. Of course, we can never be sure what insiders are thinking, we can only judge their actions.
Insiders in Amanta Healthcare both added to and reduced their holdings over the preceding 12 months. All in all though, their acquisitions outweighed the amount of shares they sold off. When you weigh that up, it is a mild positive, indicating increased alignment between shareholders and management. Zooming in, we can see that the biggest insider purchase was by company insider Jitendra Patel for ₹2.4m worth of shares, at about ₹150 per share.
These recent buys aren't the only encouraging sign for shareholders, as a look at the shareholder registry for Amanta Healthcare will reveal that insiders own a significant piece of the pie. Indeed, with a collective holding of 54%, company insiders are in control and have plenty of capital behind the venture. This makes it apparent they will be incentivised to plan for the long term - a positive for shareholders with a sit and hold strategy. In terms of absolute value, insiders have ₹4.1b invested in the business, at the current share price. That's nothing to sneeze at!
Does Amanta Healthcare Deserve A Spot On Your Watchlist?
One positive for Amanta Healthcare is that it is growing EPS. That's nice to see. Better yet, insiders are significant shareholders, and have been buying more shares. That should do plenty in prompting budding investors to undertake a bit more research - or even adding the company to their watchlists. However, before you get too excited we've discovered 4 warning signs for Amanta Healthcare (3 are significant!) that you should be aware of.
The good news is that Amanta Healthcare is not the only stock with insider buying. Here's a list of small cap, undervalued companies in IN with insider buying in the last three months!
Please note the insider transactions discussed in this article refer to reportable transactions in the relevant jurisdiction.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.